Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: THYROZOL 5 MG
Active substances:
Estonian, English, Latin
ATC code: H03BB02
Dosage form: film-coated tablet
Strength: 5mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated July 8, 2021)
Package information leaflet (PIL): EST  (last updated August 17, 2023)
Labelling:  (last updated July 8, 2021)
Indication: Treatment of hyperthyroidism, including • Conservative treatment of hyperthyroidism, especially in small or absent goitre, • Preparation for surgery in all forms of hyperthyroidism, • Preparation for radioiodine treatment particularly in patients with severe hyperthyroidism, • Intermediate therapy after treatment with radioiodine, • Prophylactic treatment in patients with sub-clinical hyperthyroidism, autonomous adenomas or a history of hyperthyroidism, in whom exposure to iodine is indispensable (e.g. examination with iodine-containing contrast media).
Safety features: Yes
Marketing authorization holder: Merck Serono SIA 
Marketing authorization number: 594608 
Marketing authorization issued on: August 22, 2008 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1114681  THYROZOL 5 MG  film-coated tablet  5mg 20TK  Prescription           
1114692  THYROZOL 5 MG  film-coated tablet  5mg 50TK  Prescription      03.04.2024     
1114704  THYROZOL 5 MG  film-coated tablet  5mg 100TK  Prescription           
1332650  THYROZOL 5 MG  film-coated tablet  5mg 30TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere